Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00738712 · ClinicalTrials.gov registry record · NA
Refinement and Assessment of New Magnetic Resonance Imaging (MRI) Technologies for Vascular, Abdominal, and Pelvic Exams
A NA study, sponsored by University of Michigan.
- Completed
- Registry status
- NA
- Development phase
- 20
- Enrollment target
NCT00738712 is a NA study that has completed, run by University of Michigan. The registered enrollment target is 20 participants.
The verdict
NCT00738712, a NA study, has completed, sponsored by University of Michigan.
- COMPLETED
- Registry status
- NA
- Development phase
- 20 participants
- Enrollment target
Study Summary
This study is being done to assess new Magnetic Resonance Imaging (MRI) technologies designed to improve MRI examinations of the vascular structures, abdomen, and pelvis regions.
Interventions
- PROCEDURE MRI Magnetic Resonance Imaging
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2011-05-02 |
| Est. Completion | 2020-01-14 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00738712
The ClinicalTrials.gov registry entry for NCT00738712 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Michigan, which has 1,327 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which MRI Magnetic Resonance Imaging is the first listed.
NCT00738712 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00738712 about?
NCT00738712 is a clinical study titled "Refinement and Assessment of New Magnetic Resonance Imaging (MRI) Technologies for Vascular, Abdominal, and Pelvic Exams". This study is being done to assess new Magnetic Resonance Imaging (MRI) technologies designed to improve MRI examinations of the vascular structures, abdomen, and pelvis regions.
What is the current status of trial NCT00738712?
This trial is currently completed. It is a NA study. The enrollment target is 20 participants. The study started on 2011-05-02. Estimated completion is 2020-01-14.
What interventions are being tested in trial NCT00738712?
The interventions under investigation include: MRI Magnetic Resonance Imaging (PROCEDURE).
Who is sponsoring clinical trial NCT00738712?
This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.